Ketamine/psilocybin retreat screening, off-clinic risk simulator.
Retreats often run in remote jungle or mountain locations far from clinical care.
Remote settings add delay before any emergency help arrives.
Placeholder: isolation is a core risk multiplier for medical events.
Facilitators are not always licensed medical providers on-site.
Rough terrain can slow both onset response and outside rescue.
Fewer emergency resources mean slower response to adverse events.
Clinics carry equipment retreats typically do not stock.
Placeholder: infrastructure level directly shapes emergency response capability.
Ketamine and psilocybin carry distinct cardiac and psychiatric concerns.
Some retreats add nurses or telemedicine to offset gaps.
A screening form collects history before travel or acceptance.
Questionnaires rely on honest, complete self-disclosure.
Placeholder: thoroughness rises as more risk factors are actively surfaced.
Cardiac, psychiatric, medication, and pregnancy status are typical.
A call or video screen can clarify ambiguous answers.
Specific answers trigger disqualifying or monitoring flags.
Uncontrolled hypertension or arrhythmia raise dosing concerns.
Placeholder: overall risk climbs sharply as flags accumulate.
Psychosis or mania history is a common exclusion criterion.
Certain medications conflict with ketamine or psilocybin.
Combined infrastructure and risk data drive a final gate decision.
Low risk and adequate infrastructure favor acceptance.
Placeholder: the gate should default to caution when data is incomplete.
Borderline cases may be accepted with added supervision.
High-risk cases are redirected to a clinical setting.